vs

Side-by-side financial comparison of DTE Energy (DTE) and TENET HEALTHCARE CORP (THC). Click either name above to swap in a different company.

TENET HEALTHCARE CORP is the larger business by last-quarter revenue ($5.5B vs $4.4B, roughly 1.2× DTE Energy). TENET HEALTHCARE CORP runs the higher net margin — 11.7% vs 8.3%, a 3.3% gap on every dollar of revenue. On growth, DTE Energy posted the faster year-over-year revenue change (28.9% vs 9.0%). Over the past eight quarters, DTE Energy's revenue compounded faster (16.9% CAGR vs 1.5%).

DTE Energy is a Detroit-based diversified energy company involved in the development and management of energy-related businesses and services in the United States and Canada. Its operating units include an electric utility serving 2.2 million customers and a natural gas utility serving 1.3 million customers in Michigan.

Tenet Healthcare Corporation is an American for-profit multinational healthcare services company based in Dallas. Through its brands, subsidiaries, joint ventures, and partnerships including United Surgical Partners International (USPI), the company operates 65 hospitals and over 450 healthcare facilities. Tenet also runs Conifer Health Solutions, which provides healthcare support services to health systems and other clients.

DTE vs THC — Head-to-Head

Bigger by revenue
THC
THC
1.2× larger
THC
$5.5B
$4.4B
DTE
Growing faster (revenue YoY)
DTE
DTE
+19.9% gap
DTE
28.9%
9.0%
THC
Higher net margin
THC
THC
3.3% more per $
THC
11.7%
8.3%
DTE
Faster 2-yr revenue CAGR
DTE
DTE
Annualised
DTE
16.9%
1.5%
THC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
DTE
DTE
THC
THC
Revenue
$4.4B
$5.5B
Net Profit
$369.0M
$644.0M
Gross Margin
Operating Margin
15.9%
15.4%
Net Margin
8.3%
11.7%
Revenue YoY
28.9%
9.0%
Net Profit YoY
26.4%
12.6%
EPS (diluted)
$1.78
$4.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DTE
DTE
THC
THC
Q4 25
$4.4B
$5.5B
Q3 25
$3.5B
$5.3B
Q2 25
$3.4B
$5.3B
Q1 25
$4.4B
$5.2B
Q4 24
$3.4B
$5.1B
Q3 24
$2.9B
$5.1B
Q2 24
$2.9B
$5.1B
Q1 24
$3.2B
$5.4B
Net Profit
DTE
DTE
THC
THC
Q4 25
$369.0M
$644.0M
Q3 25
$419.0M
$579.0M
Q2 25
$229.0M
$522.0M
Q1 25
$445.0M
$622.0M
Q4 24
$292.0M
$572.0M
Q3 24
$477.0M
$681.0M
Q2 24
$322.0M
$477.0M
Q1 24
$313.0M
$2.3B
Operating Margin
DTE
DTE
THC
THC
Q4 25
15.9%
15.4%
Q3 25
17.6%
16.8%
Q2 25
12.5%
15.6%
Q1 25
14.1%
18.1%
Q4 24
16.2%
16.2%
Q3 24
17.8%
21.3%
Q2 24
17.5%
14.9%
Q1 24
16.0%
61.2%
Net Margin
DTE
DTE
THC
THC
Q4 25
8.3%
11.7%
Q3 25
11.9%
10.9%
Q2 25
6.7%
9.9%
Q1 25
10.0%
11.9%
Q4 24
8.5%
11.3%
Q3 24
16.4%
13.3%
Q2 24
11.2%
9.3%
Q1 24
9.7%
43.5%
EPS (diluted)
DTE
DTE
THC
THC
Q4 25
$1.78
$4.22
Q3 25
$2.01
$3.86
Q2 25
$1.10
$3.14
Q1 25
$2.14
$4.27
Q4 24
$1.41
$3.79
Q3 24
$2.30
$4.89
Q2 24
$1.55
$2.64
Q1 24
$1.51
$21.38

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DTE
DTE
THC
THC
Cash + ST InvestmentsLiquidity on hand
$208.0M
$2.9B
Total DebtLower is stronger
$23.8B
$13.1B
Stockholders' EquityBook value
$12.3B
$4.2B
Total Assets
$54.1B
$29.7B
Debt / EquityLower = less leverage
1.93×
3.10×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DTE
DTE
THC
THC
Q4 25
$208.0M
$2.9B
Q3 25
$34.0M
$3.0B
Q2 25
$32.0M
$2.6B
Q1 25
$33.0M
$3.0B
Q4 24
$24.0M
$3.0B
Q3 24
$969.0M
$4.1B
Q2 24
$20.0M
$2.9B
Q1 24
$292.0M
$2.5B
Total Debt
DTE
DTE
THC
THC
Q4 25
$23.8B
$13.1B
Q3 25
$24.5B
$13.1B
Q2 25
$22.9B
$13.1B
Q1 25
$21.8B
$13.1B
Q4 24
$20.7B
$13.1B
Q3 24
$20.5B
$12.8B
Q2 24
$19.3B
$12.8B
Q1 24
$19.2B
$12.8B
Stockholders' Equity
DTE
DTE
THC
THC
Q4 25
$12.3B
$4.2B
Q3 25
$12.2B
$4.0B
Q2 25
$11.7B
$3.7B
Q1 25
$11.9B
$4.2B
Q4 24
$11.7B
$4.2B
Q3 24
$11.6B
$3.8B
Q2 24
$11.1B
$3.5B
Q1 24
$11.2B
$3.5B
Total Assets
DTE
DTE
THC
THC
Q4 25
$54.1B
$29.7B
Q3 25
$52.0B
$29.4B
Q2 25
$50.2B
$28.7B
Q1 25
$49.6B
$29.2B
Q4 24
$48.8B
$28.9B
Q3 24
$49.8B
$29.4B
Q2 24
$47.8B
$29.3B
Q1 24
$45.9B
$28.9B
Debt / Equity
DTE
DTE
THC
THC
Q4 25
1.93×
3.10×
Q3 25
2.01×
3.26×
Q2 25
1.96×
3.49×
Q1 25
1.83×
3.13×
Q4 24
1.77×
3.14×
Q3 24
1.76×
3.33×
Q2 24
1.74×
3.67×
Q1 24
1.72×
3.70×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DTE
DTE
THC
THC
Operating Cash FlowLast quarter
$1.0B
$731.0M
Free Cash FlowOCF − Capex
$367.0M
FCF MarginFCF / Revenue
6.6%
Capex IntensityCapex / Revenue
6.6%
Cash ConversionOCF / Net Profit
2.84×
1.14×
TTM Free Cash FlowTrailing 4 quarters
$2.5B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DTE
DTE
THC
THC
Q4 25
$1.0B
$731.0M
Q3 25
$632.0M
$1.1B
Q2 25
$709.0M
$936.0M
Q1 25
$1.0B
$815.0M
Q4 24
$1.1B
$-331.0M
Q3 24
$758.0M
$1.0B
Q2 24
$759.0M
$747.0M
Q1 24
$1.0B
$586.0M
Free Cash Flow
DTE
DTE
THC
THC
Q4 25
$367.0M
Q3 25
$778.0M
Q2 25
$743.0M
Q1 25
$642.0M
Q4 24
$-661.0M
Q3 24
$829.0M
Q2 24
$602.0M
Q1 24
$346.0M
FCF Margin
DTE
DTE
THC
THC
Q4 25
6.6%
Q3 25
14.7%
Q2 25
14.1%
Q1 25
12.3%
Q4 24
-13.0%
Q3 24
16.2%
Q2 24
11.8%
Q1 24
6.4%
Capex Intensity
DTE
DTE
THC
THC
Q4 25
6.6%
Q3 25
5.3%
Q2 25
3.7%
Q1 25
3.3%
Q4 24
6.5%
Q3 24
4.2%
Q2 24
2.8%
Q1 24
4.5%
Cash Conversion
DTE
DTE
THC
THC
Q4 25
2.84×
1.14×
Q3 25
1.51×
1.83×
Q2 25
3.10×
1.79×
Q1 25
2.29×
1.31×
Q4 24
3.71×
-0.58×
Q3 24
1.59×
1.53×
Q2 24
2.36×
1.57×
Q1 24
3.33×
0.25×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DTE
DTE

Electric Segment$1.8B40%
Residential$723.0M16%
Gas Segment$651.0M15%
Commercial$524.0M12%
Other$333.0M8%
DTE Vantage Segment$176.0M4%
Industrial$159.0M4%
End User Transportation$69.0M2%
Intermediate Transportation$25.0M1%

THC
THC

Other$2.9B52%
Health Care Patient Service$1.4B25%
Equity Method Investment Nonconsolidated Investee Or Group Of Investees$1.2B22%
Health Care Other Sources$56.0M1%

Related Comparisons